FMI Holdings Ltd., formerly Forbes Medi-Tech Inc., is a life sciences company focused on evidence-based nutritional solutions. The Company provide products and cholesterol-lowering ingredients for use in functional foods and dietary supplements, or nutraceuticals. It developed and commercialized the Reducol plant sterol blend, which has undergone clinical studies in various food matrices and has been shown to lower LDL cholesterol levels safely and naturally. The wholly owned subsidiaries of the Company include Forbes Medi-Tech (USA) Inc. and Forbes Medi-Tech (Research) Inc. On August 26, 2010, the Company completed the sale of its assets (Asset Sale) to Pharmachem Laboratories, Inc.